45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
25,287
Insurances with rates
37
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 8900001 | HC KYMRIAH UP TO 600M CAR POSITIVE CELLS | $3,750,000 | $3,750,000 | — | — | 13 |
| 8900001 | HC KYMRIAH UP TO 600M CAR POSITIVE CELLS | $3,750,000 | $3,750,000 | — | — | 21 |
| 8900003 | HC BREYANZI UP TO 110M CAR POSITIVE CELLS | $3,750,000 | $3,750,000 | — | — | 13 |
| 8900003 | HC BREYANZI UP TO 110M CAR POSITIVE CELLS | $3,750,000 | $3,750,000 | — | — | 21 |
| 67457084744Q5114 | TRASTUZUMAB-DKST 420 MG IV SOLR | $2,712,688 | $2,712,688 | — | — | 13 |
| 67457084744Q5114 | TRASTUZUMAB-DKST 420 MG IV SOLR | $2,712,688 | $2,712,688 | — | — | 22 |
| 59572077501J0896 | LUSPATERCEPT-AAMT 75 MG SC SOLR | $2,193,651 | $2,193,651 | — | — | 13 |
| 59572077501J0896 | LUSPATERCEPT-AAMT 75 MG SC SOLR | $2,193,651 | $2,193,651 | — | — | 23 |
| 71336100301J0225 | VUTRISIRAN SODIUM 25 MG/0.5ML SC SOSY | $328,226 | $328,226 | — | — | 13 |
| 71336100301J0225 | VUTRISIRAN SODIUM 25 MG/0.5ML SC SOSY | $328,226 | $328,226 | — | — | 23 |
| 8700004 | HC CAR-T CELL ADMIN AUTOLOGOUS | $202,585 | $202,585 | — | — | 12 |
| 8700004 | HC CAR-T CELL ADMIN AUTOLOGOUS | $202,585 | $202,585 | — | — | 27 |
| 8700008 | HC CAR-T CELL ADMIN AUTOLOGOUS | $202,585 | $202,585 | — | — | 12 |
| 8700008 | HC CAR-T CELL ADMIN AUTOLOGOUS | $202,585 | $202,585 | — | — | 24 |
| 2705068 | HC HEARTMATE 3 | $164,500 | $164,500 | — | — | 14 |
| 2705068 | HC HEARTMATE 3 | $164,500 | $164,500 | — | — | 28 |
| 4901311 | HC IR-ATHERECTOMY AND STENT FEM/POP ARTERY BILATER | $162,554 | $162,554 | — | — | 13 |
| 4901311 | HC IR-ATHERECTOMY AND STENT FEM/POP ARTERY BILATERAL | $162,554 | $162,554 | — | — | 25 |
| 4901315 | HC IR-ATHERECTOMY AND STENT TIBIAL/PERONEAL ARTERY | $152,186 | $152,186 | — | — | 13 |
| 4901315 | HC IR-ATHERECTOMY AND STENT TIBIAL/PERONEAL ARTERY BILATERAL | $152,186 | $152,186 | — | — | 25 |
| 2705067 | HC PUMP HEART IMPLANT | $141,372 | $141,372 | — | — | 14 |
| 2705067 | HC PUMP HEART IMPLANT | $141,372 | $141,372 | — | — | 28 |
| 2703388 | HC HEART MATE III | $121,159 | $121,159 | — | — | 14 |
| 2703388 | HC HEART MATE III | $121,159 | $121,159 | — | — | 28 |
| 4800244 | HC RF ABLATION OF AFIB/PVI | $119,843 | $119,843 | — | — | 13 |
| 4800244 | HC RF ABLATION OF AFIB/PVI | $119,843 | $119,843 | — | — | 23 |
| 71336100101J0223 | GIVOSIRAN SODIUM 189 MG/ML SC SOLN | $117,261 | $117,261 | — | — | 13 |
| 71336100101J0223 | GIVOSIRAN SODIUM 189 MG/ML SC SOLN | $117,261 | $117,261 | — | — | 23 |
| 61755001001J1305 | EVINACUMAB-DGNB 1200 MG/8ML IV SOLN | $116,013 | $116,013 | — | — | 13 |
| 61755001001J1305 | EVINACUMAB-DGNB 1200 MG/8ML IV SOLN | $116,013 | $116,013 | — | — | 23 |
| 8700005 | HC BLD DRV T LYMPHCYT CAR-T COLLECTION | $115,763 | $115,763 | — | — | 12 |
| 8700005 | HC BLD DRV T LYMPHCYT CAR-T COLLECTION | $115,763 | $115,763 | — | — | 28 |
| 4800241 | HC RF ABLATION OF AFLUTTER/SVT/WPW | $114,369 | $114,369 | — | — | 13 |
| 4800241 | HC RF ABLATION OF AFLUTTER/SVT/WPW | $114,369 | $114,369 | — | — | 23 |
| 2700868 | HC CV HEARTMATE 2 LVAS | $114,297 | $114,297 | — | — | 14 |
| 2700868 | HC CV HEARTMATE 2 LVAS | $114,297 | $114,297 | — | — | 27 |
| 4901454 | HC UNI REVSC EVASC FPVT ST ATHRC UNI CPLX LES 1ST VSL | $112,620 | $112,620 | — | — | 13 |
| 4901454 | HC UNI REVSC EVASC FPVT ST ATHRC UNI CPLX LES 1ST VSL | $112,620 | $112,620 | — | — | 24 |
| 00310453530J9347 | TREMELIMUMAB-ACTL 300 MG/15ML IV SOLN | $111,649 | $111,649 | — | — | 13 |
| 00310453530J9347 | TREMELIMUMAB-ACTL 300 MG/15ML IV SOLN | $111,649 | $111,649 | — | — | 23 |
| 50242055401C9399 | OCRELIZUMAB-HYALURONIDASE-OCSQ 920-23000 MG-UT/23M | $108,496 | $108,496 | — | — | 13 |
| 50242055401C9399 | OCRELIZUMAB-HYALURONIDASE-OCSQ 920-23000 MG-UT/23M | $108,496 | $108,496 | — | — | 25 |
| 2703387 | HC HEART MATE II | $103,000 | $103,000 | — | — | 14 |
| 2703387 | HC HEART MATE II | $103,000 | $103,000 | — | — | 28 |
| 2705280 | HC TRICLIP SYSTEM | $101,400 | $101,400 | — | — | 14 |
| 2705280 | HC TRICLIP SYSTEM | $101,400 | $101,400 | — | — | 25 |
| 4800242 | HC RF ABLATION OF VT INCLUDES 3D MAPPING | $100,966 | $100,966 | — | — | 13 |
| 4800242 | HC RF ABLATION OF VT INCLUDES 3D MAPPING | $100,966 | $100,966 | — | — | 23 |
| 3330030 | HC STEREOTACTIC RADIOSURGERY CO60 | $100,767 | $100,767 | — | — | 13 |
| 3330030 | HC STEREOTACTIC RADIOSURGERY CO60 | $100,767 | $100,767 | — | — | 24 |
Showing top 50 of 25,287 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.